Related Experiment Videos
[Megadose steroid therapy in papillitis with progressive visual loss]
1Klinik für Augenheilkunde, Medizinischen Universität zu Lübeck.
Klinische Monatsblatter Fur Augenheilkunde
|December 1, 1990
Summary
Megadose steroid therapy, specifically methylprednisolone, showed significant visual recovery in papillitis patients. An antiedematous treatment with mannitol also proved effective, suggesting potential benefits for vision loss in selected papillitis cases.
Area of Science:
- Ophthalmology
- Neurology
Background:
- Papillitis, often leading to progressive visual loss, presents a therapeutic challenge.
- The efficacy of high-dose corticosteroids in managing optic neuritis is recognized.
Observation:
- Two patients with papillitis and progressive visual loss received high-dose intravenous methylprednisolone (1000 mg/day), resulting in prompt and substantial visual recovery.
- Two other patients with similar conditions, ineligible for steroid therapy due to contraindications, were treated with mannitol infusions, an antiedematous agent.
- These patients also experienced rapid visual acuity return, comparable to those receiving steroid therapy.
Findings:
- Megadose steroid therapy appears effective in managing papillitis with severe vision loss.
- Purely antiedematous treatment with mannitol demonstrated comparable efficacy to megadose steroids in this context.
- The antiedematous effect may be a key mechanism underlying the therapeutic benefits observed.
Implications:
- High-dose methylprednisolone and mannitol infusions represent potential therapeutic options for selected cases of papillitis.
- Further research is warranted to elucidate the precise mechanisms and optimize treatment protocols for papillitis.
- These findings could inform clinical practice for managing vision-threatening papillitis.